Login / Signup

What We Have Learned From Adjuvant Therapy for Resected EGFR-Mutant Non-Small-Cell Lung Cancer.

Si-Yang LiuWen-Zhao ZhongYi-Long Wu
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Keyphrases
  • small cell lung cancer
  • epidermal growth factor receptor
  • tyrosine kinase
  • lymph node
  • wild type
  • prognostic factors